257 related articles for article (PubMed ID: 17495597)
1. Concerted actions of cholesteryl ester transfer protein and phospholipid transfer protein in type 2 diabetes: effects of apolipoproteins.
Dallinga-Thie GM; Dullaart RP; van Tol A
Curr Opin Lipidol; 2007 Jun; 18(3):251-7. PubMed ID: 17495597
[TBL] [Abstract][Full Text] [Related]
2. Role of lipases, lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus.
de Vries R; Borggreve SE; Dullaart RP
Clin Lab; 2003; 49(11-12):601-13. PubMed ID: 14651331
[TBL] [Abstract][Full Text] [Related]
3. Decrease of hepatic triglyceride lipase levels and increase of cholesteryl ester transfer protein levels in patients with primary biliary cirrhosis: relationship to abnormalities in high-density lipoprotein.
Hiraoka H; Yamashita S; Matsuzawa Y; Kubo M; Nozaki S; Sakai N; Hirano K; Kawata S; Tarui S
Hepatology; 1993 Jul; 18(1):103-10. PubMed ID: 8325601
[TBL] [Abstract][Full Text] [Related]
4. Where are we with high-density lipoprotein raising and inhibition of cholesteryl ester transfer for heart disease risk reduction?
Schaefer EJ; Asztalos BF
Curr Opin Cardiol; 2007 Jul; 22(4):373-8. PubMed ID: 17556892
[TBL] [Abstract][Full Text] [Related]
5. Atorvastatin affects low density lipoprotein and non-high density lipoprotein cholesterol relations with apolipoprotein B in type 2 diabetes mellitus: modification by triglycerides and cholesteryl ester transfer protein.
Kappelle PJ; Zwang L; Huisman MV; Banga JD; Sluiter WJ; Dallinga-Thie GM; Dullaart RP
Expert Opin Ther Targets; 2009 Jul; 13(7):743-51. PubMed ID: 19505224
[TBL] [Abstract][Full Text] [Related]
6. Modulation of plasma cholesteryl ester transfer protein activity by unsaturated fatty acids in Tunisian type 2 diabetic women.
Smaoui M; Hammami S; Attia N; Chaaba R; Abid N; Kilani N; Kchaou H; Mahjoub S; Abid M; Hammami M
Nutr Metab Cardiovasc Dis; 2006 Jan; 16(1):44-53. PubMed ID: 16399491
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein-B subclasses as acceptors of cholesteryl esters transferred by CETP.
Lee DM; Alaupovic P; Knight-Gibson C; Bagdade JD
Eur J Clin Invest; 2008 Oct; 38(10):734-42. PubMed ID: 18761668
[TBL] [Abstract][Full Text] [Related]
8. Increased cholesteryl ester transfer protein activity in impaired glucose tolerance: relationship to high density lipoprotein metabolism.
Pietzsch J; Fuecker K
Croat Med J; 2003 Apr; 44(2):171-7. PubMed ID: 12698508
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein-like particles and cholesteryl esters in human Bruch's membrane: initial characterization.
Li CM; Chung BH; Presley JB; Malek G; Zhang X; Dashti N; Li L; Chen J; Bradley K; Kruth HS; Curcio CA
Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2576-86. PubMed ID: 15980251
[TBL] [Abstract][Full Text] [Related]
10. Remnant-like particles (RLP) from NIDDM patients with apolipoprotein E3/3 phenotype stimulate cholesteryl ester synthesis in human monocyte-derived macrophages.
Saito M; Eto M; Okada M; Iwashima Y; Makino I
Artery; 1996; 22(3):155-63. PubMed ID: 8893973
[TBL] [Abstract][Full Text] [Related]
11. Expression of cholesteryl ester transfer protein in mice promotes macrophage reverse cholesterol transport.
Tanigawa H; Billheimer JT; Tohyama J; Zhang Y; Rothblat G; Rader DJ
Circulation; 2007 Sep; 116(11):1267-73. PubMed ID: 17709636
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of cholesteryl ester transfer protein activity by JTT-705 increases apolipoprotein E-containing high-density lipoprotein and favorably affects the function and enzyme composition of high-density lipoprotein in rabbits.
Zhang B; Fan P; Shimoji E; Xu H; Takeuchi K; Bian C; Saku K
Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1910-5. PubMed ID: 15331428
[TBL] [Abstract][Full Text] [Related]
13. Diabetic dyslipidaemia.
Adiels M; Olofsson SO; Taskinen MR; Borén J
Curr Opin Lipidol; 2006 Jun; 17(3):238-46. PubMed ID: 16680028
[TBL] [Abstract][Full Text] [Related]
14. Brazil nut ingestion increased plasma selenium but had minimal effects on lipids, apolipoproteins, and high-density lipoprotein function in human subjects.
Strunz CC; Oliveira TV; Vinagre JC; Lima A; Cozzolino S; Maranhão RC
Nutr Res; 2008 Mar; 28(3):151-5. PubMed ID: 19083402
[TBL] [Abstract][Full Text] [Related]
15. Plasma apolipoprotein E concentration is an important determinant of phospholipid transfer protein activity in type 2 diabetes mellitus.
Tan KC; Shiu SW; Wong Y; Wong WK; Tam S
Diabetes Metab Res Rev; 2006; 22(4):307-12. PubMed ID: 16389649
[TBL] [Abstract][Full Text] [Related]
16. High serum cholesteryl ester transfer rates and small high-density lipoproteins are associated with young age in patients with acute myocardial infarction.
Zeller M; Masson D; Farnier M; Lorgis L; Deckert V; Pais de Barros JP; Desrumaux C; Sicard P; Grober J; Blache D; Gambert P; Rochette L; Cottin Y; Lagrost L
J Am Coll Cardiol; 2007 Nov; 50(20):1948-55. PubMed ID: 17996559
[TBL] [Abstract][Full Text] [Related]
17. Influence of cholesteryl ester transfer protein, peroxisome proliferator-activated receptor alpha, apolipoprotein E, and apolipoprotein A-I polymorphisms on high-density lipoprotein cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I:A-II concentrations: the Prospective Epidemiological Study of Myocardial Infarction study.
Do HQ; Nazih H; Luc G; Arveiler D; Ferrières J; Evans A; Amouyel P; Cambien F; Ducimetière P; Bard JM
Metabolism; 2009 Mar; 58(3):283-9. PubMed ID: 19217440
[TBL] [Abstract][Full Text] [Related]
18. Plasma lipid transfer proteins.
Jiang XC; Zhou HW
Curr Opin Lipidol; 2006 Jun; 17(3):302-8. PubMed ID: 16680037
[TBL] [Abstract][Full Text] [Related]
19. Increased large VLDL particles confer elevated cholesteryl ester transfer in diabetes.
Dullaart RP; de Vries R; Kwakernaak AJ; Perton F; Dallinga-Thie GM
Eur J Clin Invest; 2015 Jan; 45(1):36-44. PubMed ID: 25402623
[TBL] [Abstract][Full Text] [Related]
20. Serum cholesteryl ester transfer protein concentrations are associated with serum levels of total cholesterol, beta-lipoprotein and apoproteins in patients with type 2 diabetes mellitus.
Inukai Y; Ito K; Hara K; Yamazaki A; Takebayashi K; Aso Y; Inukai T
Med Princ Pract; 2007; 16(5):367-72. PubMed ID: 17709925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
